Alky-lysophospholipids (ALPs) are synthetic analogs of lysophosphatidylcholines (LPCs), also called lysolecithins.
They are synthesized by replacing the acyl-group within the LPC with an alkyl group.
[1][2] ALPs are being studied for their potential antineoplastic (anti-cancer)[1] and immune-modulating effects.
[2] Their anti-tumor effects are due to modulation of intracellular signalling pathways, inducing apoptosis.
[2] Several examples including edelfosine, miltefosine, and perifosine are under development as drugs against cancer and other diseases.